259 related articles for article (PubMed ID: 15729622)
1. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion.
Zou L; Harkey MR; Henderson GL
Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622
[TBL] [Abstract][Full Text] [Related]
2. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel electrophilic metabolites of piper methysticum Forst (Kava).
Johnson BM; Qiu SX; Zhang S; Zhang F; Burdette JE; Yu L; Bolton JL; van Breemen RB
Chem Res Toxicol; 2003 Jun; 16(6):733-40. PubMed ID: 12807356
[TBL] [Abstract][Full Text] [Related]
4. Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes.
Zou L; Henderson GL; Harkey MR; Sakai Y; Li A
Phytomedicine; 2004; 11(4):285-94. PubMed ID: 15185840
[TBL] [Abstract][Full Text] [Related]
5. Kava does not display metabolic toxicity in a homogeneous cellular assay.
Zou L; Harkey MR; Henderson GL; Dike LE
Planta Med; 2004 Apr; 70(4):289-92. PubMed ID: 15095141
[TBL] [Abstract][Full Text] [Related]
6. Kava Hepatotoxicity: Are we any closer to the truth?
Anke J; Ramzan I
Planta Med; 2004 Mar; 70(3):193-6. PubMed ID: 15114493
[TBL] [Abstract][Full Text] [Related]
7. Identification of some human urinary metabolites of the intoxicating beverage kava.
Duffield AM; Jamieson DD; Lidgard RO; Duffield PH; Bourne DJ
J Chromatogr; 1989 Jul; 475():273-81. PubMed ID: 2777959
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ
Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328
[TBL] [Abstract][Full Text] [Related]
9. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro.
Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ
Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848
[TBL] [Abstract][Full Text] [Related]
10. Kavalactones fail to inhibit alcohol dehydrogenase in vitro.
Anke J; Fu S; Ramzan I
Phytomedicine; 2006 Feb; 13(3):192-5. PubMed ID: 16428028
[TBL] [Abstract][Full Text] [Related]
11. Kava kava: examining new reports of toxicity.
Clouatre DL
Toxicol Lett; 2004 Apr; 150(1):85-96. PubMed ID: 15068826
[TBL] [Abstract][Full Text] [Related]
12. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
Weiss J; Sauer A; Frank A; Unger M
Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
[TBL] [Abstract][Full Text] [Related]
13. Aqueous kava extracts do not affect liver function tests in rats.
Singh YN; Devkota AK
Planta Med; 2003 Jun; 69(6):496-9. PubMed ID: 12865965
[TBL] [Abstract][Full Text] [Related]
14. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum).
Jhoo JW; Freeman JP; Heinze TM; Moody JD; Schnackenberg LK; Beger RD; Dragull K; Tang CS; Ang CY
J Agric Food Chem; 2006 Apr; 54(8):3157-62. PubMed ID: 16608246
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
Feltenstein MW; Lambdin LC; Ganzera M; Ranjith H; Dharmaratne W; Nanayakkara NP; Khan IA; Sufka KJ
Phytother Res; 2003 Mar; 17(3):210-6. PubMed ID: 12672148
[TBL] [Abstract][Full Text] [Related]
16. Identification of C-glycoside flavonoids as potential mutagenic compounds in kava.
Jhoo JW; Ang CY; Heinze TM; Deck J; Schnackenberg LK; Beger RD; Dragull K; Tang CS
J Food Sci; 2007 Mar; 72(2):C120-5. PubMed ID: 17995826
[TBL] [Abstract][Full Text] [Related]
17. Kava hepatotoxicity: pathogenetic aspects and prospective considerations.
Teschke R
Liver Int; 2010 Oct; 30(9):1270-9. PubMed ID: 20630022
[TBL] [Abstract][Full Text] [Related]
18. The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum.
Tugcu G; Kırmızıbekmez H; Aydın A
Food Chem Toxicol; 2020 Nov; 145():111663. PubMed ID: 32827561
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
Anke J; Ramzan I
J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
[TBL] [Abstract][Full Text] [Related]
20. Kava hepatotoxicity: regulatory data selection and causality assessment.
Teschke R; Wolff A
Dig Liver Dis; 2009 Dec; 41(12):891-901. PubMed ID: 19477698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
